243
Views
4
CrossRef citations to date
0
Altmetric
Patent Evaluation

Agonistic antibodies to human glucocorticoid-induced tumor necrosis factor receptor as potential stimulators of T cell immunity for the treatment of cancer and viral infections

TolerRx, Inc. WO2006105021

Pages 567-575 | Published online: 02 May 2007
 

Abstract

The magnitude of adaptive T cell responses is controlled by costimulatory molecules, including cell-surface associated members of the tumor necrosis factor receptor (TNF-R) family that modulate T cell receptor (TCR)-dependent activation, and by a network of regulatory T (Treg) cells that downregulate effector T cell functions. The glucocorticoid-induced TNF-R (GITR) is a type I transmembrane protein that is expressed at high levels on CD4+ CD25+ Treg cells and on activated effector T cells. In vitro studies have shown that ligation of GITR with an agonistic monoclonal antibody (mAb) could abrogate the suppressive activity of Treg cells and enhance the survival, proliferation and effector functions of TCR-activated CD4+ and CD8+ T cells. Furthermore, studies in mice demonstrated that mAb-triggered GITR stimulation could also markedly augment antitumor and virus-specific T cell responses in vivo. This has suggested that agonistic anti-GITR mAbs may serve to stimulate T cell immunity for therapeutic purposes. Accordingly, the present patent application reports the generation of a novel agonistic murine mAb to human GITR that is able to reverse Treg-mediated suppression and costimulate T cell activation in vitro. Humanized versions of the mAb are also described, but without providing data on their binding and functional properties. Further studies will be needed to fully appraise the potential utility of these human mAbs for the immunotherapy of cancer or viral infections.

Patent Details

  • Title GITR binding molecules and uses therefor

  • Assignee Tolerrx, Inc.

  • Inventors Smith LM, Szymanska G, Ponath P, Rosenzweig M.

  • Priority date 25/03/05.

  • Filing date 27/03/06.

  • Publication date 05/10/06

  • Publication no. WO2006105021

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 99.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,757.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.